15/11/2017 08:01:10

Affimed to Present at the Jefferies 2017 London Healthcare Conference

Related content
07 Nov - 
Affimed Reports Financial Results for Third Quarter 201..
02 Nov - 
Affimed to Present at the 26th Annual Credit Suisse Hea..
01 Nov - 
Affimed to Present Clinical and Preclinical Data on Imm..
Related debate
24 Oct - 
der skulle komme data fra flere forsøg her snart bl.a. ..
24 Oct - 
tdt min aktieven, er dumed på denne her ?
24 Oct - 
Købte lidt igår, tror der godt kan komme nyt om deres i..

Heidelberg, Germany, November 15, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi Hoess, CEO, will present at the Jefferies 2017 London Healthcare Conference on Wednesday, November 15, 2017, at 4:00 pm GMT.

A live webcast of the conference presentation can be accessed through the "Events" section on the "Investors & Media" page of the Affimed website at www.affimed.com/events.php. A replay of the presentation will be available from Affimed's website for 30 days following the conference.

About Affimed N.V.

Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK and T cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases. For more information, please visit www.affimed.com.

Contact:

Anca Alexandru, Head of Communications, EU IR

Phone: +49 6221 64793341

E-Mail: a.alexandru@affimed.com,IR@affimed.com

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

22/11/2017 10:18:00
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

21/11/2017 15:35:27
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Alliance Trust PLC : Net Asset Value(s)

21/11/2017 13:37:22
ALLIANCE TRUST PLC                                    At the close of business on Monday 20 November 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 778.0p -       including income, 787.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding inc..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Newtek Technology Solutions Joins the VMware Cloud Provider™ Program
2
ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm
3
Sprouts Farmers Market to Present at the Barclays 2017 Eat, Sleep, Play – It’s Not All Discretionary Conference
4
Franklin Electric Launches Four New Key Dealer Tutorial Videos To Help Contractors Maximize Program Value
5
Portola Pharmaceuticals Provides Update on Bevyxxa® (betrixaban) Commercial Launch

Related stock quotes

Affimed N.V. 2.05 0.0% Stock price unchanged

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 November 2017 14:28:37
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171108.1 - EUROWEB3 - 2017-11-22 15:28:37 - 2017-11-22 14:28:37 - 1000 - Website: OKAY